The University of Chicago Header Logo

Ayman Al-Hendy

TitleProfessor
InstitutionUniversity of Chicago
DepartmentObstetrics and Gynecology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01HD106285     (BOYER, THOMAS G)Aug 9, 2021 - May 31, 2026
    NIH
    Pathological reprogramming of the m6A epitranscriptome in uterine fibroids
    Role: Co-Principal Investigator
    R01HD100367     (GONZALEZ, FRANK)Sep 26, 2019 - Aug 31, 2024
    NIH
    3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids
    Role: Co-Principal Investigator
    R01HD094378     (AL-HENDY, AYMAN ;BOYER, THOMAS G)Feb 15, 2018 - Jul 31, 2023
    NIH
    Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroids
    Role: Co-Principal Investigator
    R01ES028615     (AL-HENDY, AYMAN)Sep 15, 2017 - Jul 31, 2023
    NIH
    Gene X Environment Interactions in the Pathogenesis of Uterine Fibroids
    Role: Principal Investigator
    U54RR026140     (ADUNYAH, SAMUEL)Sep 25, 2009 - Jun 30, 2014
    NIH
    Meharry Clinical and Translational Research Center (MeTRC)
    Role: Co-Principal Investigator
    R21HD046639     (AL-HENDY, AYMAN)May 5, 2005 - Apr 30, 2008
    NIH
    Reversal of Infertility in Ovarian Failure
    Role: Principal Investigator
    R01HD046228     (AL-HENDY, AYMAN)Sep 24, 2003 - Feb 29, 2016
    NIH
    Targeting Adenovirus for Gene Therapy of Uterine Leiomyoma
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Stewart EA, Lukes AS, Venturella R, Ferreira JA, Li Y, Hunsche E, Wagman RB, Al-Hendy A. A plain language summary describing changes in pain associated with uterine fibroids among women receiving relugolix combination therapy. Pain Manag. 2024 Oct 28; 1-8. PMID: 39466126.
      Citations:    Fields:    
    2. Chiang YF, Huang KC, Huang TC, Chen HY, Ali M, Al-Hendy A, Huang PS, Hsia SM. Regulatory roles of NAMPT and NAD+ metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment. Redox Biol. 2024 Oct 26; 78:103411. PMID: 39486360; PMCID: PMC11564007.
      Citations:    
    3. Siegel EL, VanNoy B, Houghton LC, Khati N, Al-Hendy A, Marfori CQ, Zota AR. Associations Between Earlier Menarche and Fibroid Severity in Individuals Seeking Hysterectomy. J Womens Health (Larchmt). 2024 Oct 15. PMID: 39405329.
      Citations:    Fields:    
    4. Yang Q, Falahati A, Khosh A, Lastra RR, Boyer TG, Al-Hendy A. Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma. Cells. 2024 Aug 28; 13(17). PMID: 39273015; PMCID: PMC11394028.
      Citations:    Fields:    Translation:HumansCells
    5. Ciebiera M, Kociuba J, Ali M, Madueke-Laveaux OS, Yang Q, Baczkowska M, Wlodarczyk M, Zeber-Lubecka N, Zarychta E, Corachán A, Alkhrait S, Somayeh V, Malasevskaia I, Lozinski T, Laudanski P, Spaczynski R, Jakiel G, Al-Hendy A. Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies. Expert Opin Ther Targets. 2024 Aug; 28(8):669-687. PMID: 39136530.
      Citations:    Fields:    Translation:HumansAnimals
    6. Alkhrait S, Al-Hendy A, Alkelani H, Karrison T, Laveaux OSM. Surgical myomectomy followed by oral Myfembree vs standard of care (SOUL trial): Study protocol for a randomized control trial. PLoS One. 2024; 19(7):e0306053. PMID: 38954680; PMCID: PMC11218990.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    7. Alkhrait S, Omran MM, Ghasroldasht MM, Park HS, Katkhuda R, Al-Hendy A. Exosome Therapy: A Novel Approach for Enhancing Estrogen Levels in Perimenopause. Int J Mol Sci. 2024 Jun 27; 25(13). PMID: 39000181; PMCID: PMC11240923.
      Citations:    Fields:    Translation:HumansCells
    8. Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. J Comp Eff Res. 2024 08; 13(8):e230194. PMID: 38934918; PMCID: PMC11284808.
      Citations:    Fields:    Translation:Humans
    9. Yang Q, Madueke-Laveaux OS, Cun H, Wlodarczyk M, Garcia N, Carvalho KC, Al-Hendy A. Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy. Cells. 2024 Jun 26; 13(13). PMID: 38994959; PMCID: PMC11240800.
      Citations: 2     Fields:    Translation:Humans
    10. Yang Q, Falahati A, Khosh A, Vafaei S, Al-Hendy A. Targeting Bromodomain-Containing Protein 9 in Human Uterine Fibroid Cells. Reprod Sci. 2024 Jun 10. PMID: 38858328.
      Citations: 1     Fields:    
    11. Bariani MV, Grimm SL, Coarfa C, Velez Edwards DR, Yang Q, Walker CL, Ali M, Al-Hendy A. Altered extracellular matrix-related pathways accelerate the transition from normal to prefibroid myometrium in Black women. Am J Obstet Gynecol. 2024 Sep; 231(3):324.e1-324.e12. PMID: 38825029; PMCID: PMC11344675.
      Citations:    Fields:    Translation:HumansCells
    12. Bateman NW, Abulez T, Tarney CM, Bariani MV, Driscoll JA, Soltis AR, Zhou M, Hood BL, Litzi T, Conrads KA, Jackson A, Oliver J, Ganakammal SR, Schneider F, Dalgard CL, Wilkerson MD, Smith B, Borda V, O'Connor T, Segars J, Shobeiri SA, Phippen NT, Darcy KM, Al-Hendy A, Conrads TP, Maxwell GL. Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities. Am J Obstet Gynecol. 2024 Sep; 231(3):321.e1-321.e11. PMID: 38723985.
      Citations: 1     Fields:    Translation:Humans
    13. Mousaei Ghasroldasht M, Liakath Ali F, Park HS, Hadizadeh M, Weng SHS, Huff A, Vafaei S, Al-Hendy A. A Comparative Analysis of Naïve Exosomes and Enhanced Exosomes with a Focus on the Treatment Potential in Ovarian Disorders. J Pers Med. 2024 Apr 30; 14(5). PMID: 38793064; PMCID: PMC11122298.
      Citations: 1     
    14. Venturella R, Lukes AS, Wu R, McLean R, Rakov VG, Al-Hendy A. Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline. Int J Gynaecol Obstet. 2024 May; 165(2):431-441. PMID: 38576220.
      Citations:    Fields:    Translation:Humans
    15. Leal CRV, Vannuccini S, Jain V, Dolmans MM, Di Spiezio Sardo A, Al-Hendy A, Reis FM. Abnormal uterine bleeding: The well-known and the hidden face. J Endometr Uterine Disord. 2024 Jun; 6. PMID: 38764520; PMCID: PMC11101194.
      Citations:    
    16. Vafaei S, Alkhrait S, Yang Q, Ali M, Al-Hendy A. Empowering Strategies for Lifestyle Interventions, Diet Modifications, and Environmental Practices for Uterine Fibroid Prevention; Unveiling the LIFE UP Awareness. Nutrients. 2024 Mar 12; 16(6). PMID: 38542717; PMCID: PMC10975324.
      Citations: 1     Fields:    Translation:Humans
    17. Othman ER, Al-Hendy A, Mostafa R, Lambalk CB, Mijatovic V. Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of Hormonal Agents. Int J Womens Health. 2024; 16:309-321. PMID: 38435758; PMCID: PMC10908275.
      Citations:    
    18. Laganà AS, Romano A, Vanhie A, Bafort C, Götte M, Aaltonen LA, Mas A, De Bruyn C, Van den Bosch T, Coosemans A, Guerriero S, Haimovich S, Tanos V, Bongers M, Barra F, Al-Hendy A, Chiantera V, Leone Roberti Maggiore U. Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper. Gynecol Obstet Invest. 2024; 89(2):73-86. PMID: 38382486.
      Citations: 1     Fields:    Translation:Humans
    19. Park HS, Seok J, Cetin E, Ghasroldasht MM, Liakath Ali F, Mohammed H, Alkelani H, Al-Hendy A. Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy-induced ovarian damage in a mouse model. Am J Obstet Gynecol. 2024 07; 231(1):111.e1-111.e18. PMID: 38378099.
      Citations: 1     Fields:    Translation:AnimalsCells
    20. Wlodarczyk M, Ciebiera M, Nowicka G, Lozinski T, Ali M, Al-Hendy A. Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms. Nutrients. 2024 Feb 17; 16(4). PMID: 38398883; PMCID: PMC10893337.
      Citations:    Fields:    Translation:Humans
    21. Seok J, Park HS, Cetin E, Ghasroldasht MM, Liakath FB, Al-Hendy A. The potent paracrine effect of umbilical cord mesenchymal stem cells mediates mitochondrial quality control to restore chemotherapy-induced damage in ovarian granulosa cells. Biomed Pharmacother. 2024 Mar; 172:116263. PMID: 38350369.
      Citations:    Fields:    Translation:HumansCells
    22. Saha P, Weigle IQ, Slimmon N, Poli PB, Patel P, Zhang X, Cao Y, Michalkiewicz J, Gomm A, Zhang C, Tanzi RE, Dylla N, Al-Hendy A, Sisodia SS. Early modulation of the gut microbiome by female sex hormones alters amyloid pathology and microglial function. Sci Rep. 2024 01 21; 14(1):1827. PMID: 38246956; PMCID: PMC10800351.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    23. Al-Hendy A, Segars JH, Taylor HS, González F, Siblini H, Zamah M, Alkelani H, Singh B, Flores VA, Christman GM, Johnson JJ, Huang H, Zhang H. Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids. BMJ Open. 2024 01 12; 14(1):e078989. PMID: 38216200; PMCID: PMC10806662.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    24. Yang Q, Vafaei S, Falahati A, Khosh A, Bariani MV, Omran MM, Bai T, Siblini H, Ali M, He C, Boyer TG, Al-Hendy A. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells. Int J Mol Sci. 2024 Jan 11; 25(2). PMID: 38255982; PMCID: PMC10815284.
      Citations: 3     Fields:    Translation:HumansCells
    25. Fadel HE, Al-Hendy A. A Glimpse into Gynecologic Practice During the Islamic Golden Age. Reprod Sci. 2024 05; 31(5):1227-1233. PMID: 38168856; PMCID: PMC11090949.
      Citations:    Fields:    Translation:Humans
    26. Liakath Ali F, Park HS, Beckman A, Eddy AC, Alkhrait S, Ghasroldasht MM, Al-Hendy A, Raheem O. Fertility Protection, A Novel Concept: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Protect against Chemotherapy-Induced Testicular Cytotoxicity. Int J Mol Sci. 2023 Dec 20; 25(1). PMID: 38203232; PMCID: PMC10779299.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    27. Garcia N, Ulin M, Yang Q, Ali M, Bosland MC, Zeng W, Chen L, Al-Hendy A. Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma. Cells. 2023 12 13; 12(24). PMID: 38132150; PMCID: PMC10741838.
      Citations: 1     Fields:    Translation:HumansAnimals
    28. Vafaei S, Ciebiera M, Omran MM, Ghasroldasht MM, Yang Q, Leake T, Wolfe R, Ali M, Al-Hendy A. Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach). Int J Mol Sci. 2023 Nov 04; 24(21). PMID: 37958957; PMCID: PMC10648339.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    29. Ali M, Ciebiera M, Wlodarczyk M, Alkhrait S, Maajid E, Yang Q, Hsia SM, Al-Hendy A. Current and Emerging Treatment Options for Uterine Fibroids. Drugs. 2023 Dec; 83(18):1649-1675. PMID: 37922098.
      Citations: 1     Fields:    Translation:Humans
    30. Madueke-Laveaux OS, Tanna R, Al-Hendy A. Can We Treat Racism with Baby Aspirin? Curr Opin Gynecol Obstet. 2023; 5(1):462-466. PMID: 38093953; PMCID: PMC10718571.
      Citations:    
    31. Schulmann T, Stewart EA, Al-Hendy A, Lukes AS, Madueke-Laveaux OS, Zhu E, Proehl S, Marsh EE. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study. Am J Obstet Gynecol. 2024 02; 230(2):237.e1-237.e11. PMID: 37863160.
      Citations:    Fields:    Translation:Humans
    32. Yang Q, Ali M, Bariani MV, Vafaei S, Al-Hendy A. Endocrine-disrupting chemicals and epigenetic reprogramming in developmental origin of uterine fibroids. Sci Prog. 2023 Oct-Dec; 106(4):368504231215601. PMID: 38189295; PMCID: PMC10775733.
      Citations: 1     Fields:    Translation:Humans
    33. Bai T, Ali M, Somers B, Yang Q, McKinney S, Al-Hendy A. The combination of natural compounds Crila and epigallocatechin gallate showed enhanced antiproliferative effects on human uterine fibroid cells compared with single treatments. F S Sci. 2023 11; 4(4):341-349. PMID: 37739343.
      Citations: 1     Fields:    Translation:HumansCells
    34. Bariani MV, Cui YH, Ali M, Bai T, Grimm SL, Coarfa C, Walker CL, He YY, Yang Q, Al-Hendy A. TGFß signaling links early life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells. Cell Mol Life Sci. 2023 Sep 09; 80(10):288. PMID: 37689587; PMCID: PMC10492698.
      Citations: 5     Fields:    Translation:AnimalsCells
    35. Al-Hendy A, Venturella R, Arjona Ferreira JC, Li Y, Soulban G, Wagman RB, Lukes AS. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids. Am J Obstet Gynecol. 2023 12; 229(6):662.e1-662.e25. PMID: 37666383.
      Citations: 6     Fields:    Translation:Humans
    36. Yang Q, Ali M, Treviño LS, Mas A, Al-Hendy A. Developmental reprogramming of myometrial stem cells by endocrine disruptor linking to risk of uterine fibroids. Cell Mol Life Sci. 2023 Aug 31; 80(9):274. PMID: 37650943; PMCID: PMC10471700.
      Citations: 5     Fields:    Translation:Animals
    37. Ciebiera M, Madueke-Laveaux OS, Feduniw S, Ulin M, Spaczynski R, Zgliczynska M, Baczkowska M, Zarychta E, Lozinski T, Ali M, Al-Hendy A. GnRH agonists and antagonists in therapy of symptomatic uterine fibroids - current roles and future perspectives. Expert Opin Pharmacother. 2023 Sep-Dec; 24(16):1799-1809. PMID: 37602464.
      Citations: 4     Fields:    Translation:Humans
    38. Venable SR, Al-Hendy A. Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy). Adv Ther. 2023 10; 40(10):4127-4133. PMID: 37568061; PMCID: PMC10499739.
      Citations:    Fields:    Translation:Humans
    39. Al-Hendy A, Lukes AS, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids. J Comp Eff Res. 2023 08; 12(8):e230069. PMID: 37477173; PMCID: PMC10508299.
      Citations:    Fields:    Translation:Humans
    40. Yang Q, Ali M, Treviño LS, Mas A, Ismail N, Al-Hendy A. Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids. Int J Mol Sci. 2023 Jul 19; 24(14). PMID: 37511399; PMCID: PMC10380326.
      Citations: 7     Fields:    Translation:HumansCells
    41. Al-Hendy A, Zhou YF, Faustmann T, Groettrup-Wolfers E, Laapas K, Parke S, Seitz C. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial. F S Sci. 2023 Nov; 4(4):317-326. PMID: 37437885.
      Citations: 1     Fields:    Translation:Humans
    42. Park HS, Cetin E, Siblini H, Seok J, Alkelani H, Alkhrait S, Liakath Ali F, Mousaei Ghasroldasht M, Beckman A, Al-Hendy A. Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles to Treat PCOS. Int J Mol Sci. 2023 Jul 06; 24(13). PMID: 37446328; PMCID: PMC10342552.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    43. Park HS, Chugh RM, Seok J, Cetin E, Mohammed H, Siblini H, Liakath Ali F, Ghasroldasht MM, Alkelani H, Elsharoud A, Ulin M, Esfandyari S, Al-Hendy A. Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage. Stem Cell Res Ther. 2023 06 20; 14(1):165. PMID: 37340468; PMCID: PMC10283237.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    44. Bariani MV, Cui YH, Ali M, Bai T, Grimm SL, Coarfa C, Walker CL, He YY, Yang Q, Al-Hendy A. TGFß signaling links early-life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells. Res Sq. 2023 Jun 07. PMID: 37333266; PMCID: PMC10274956.
      Citations:    
    45. Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, Critchley HO, Li Y, McKain L, Arjona Ferreira JC, Langenberg AG, Wagman RB, Stewart EA. A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies. Pain Manag. 2023 Apr; 13(4):205-211. PMID: 37183454.
      Citations:    Fields:    Translation:Humans
    46. Ali M, Stone D, Laknaur A, Yang Q, Al-Hendy A. EZH2 activates Wnt/ß-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate. F S Sci. 2023 08; 4(3):239-256. PMID: 37182601; PMCID: PMC10527015.
      Citations: 1     Fields:    Translation:HumansCells
    47. Yang Q, Al-Hendy A. The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma. Int J Mol Sci. 2023 Apr 27; 24(9). PMID: 37175660; PMCID: PMC10178470.
      Citations: 4     Fields:    Translation:HumansCells
    48. Cooper NAM, Rivas C, Munro MG, Critchley HOD, Clark TJ, Matteson KA, Papadantonaki R, Yorke S, Tan A, Bofill Rodriguez M, Bongers M, Al-Hendy A, Bahamondes L, Connolly A, Farquhar C, Gray Valbrun T, Hickey M, Taylor HS, Toub D, Vannuccini S, Iliodromiti S, Khan K. Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set. BJOG. 2023 10; 130(11):1337-1345. PMID: 37055716.
      Citations: 3     Fields:    Translation:Humans
    49. Ali M, Ciebiera M, Vafaei S, Alkhrait S, Chen HY, Chiang YF, Huang KC, Feduniw S, Hsia SM, Al-Hendy A. Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics. Cells. 2023 04 09; 12(8). PMID: 37190026; PMCID: PMC10136461.
      Citations: 7     Fields:    Translation:Humans
    50. Yang Q, Al-Hendy A. Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids. Int J Mol Sci. 2023 Mar 17; 24(6). PMID: 36982852; PMCID: PMC10051203.
      Citations: 9     Fields:    Translation:HumansCells
    51. Ali M, Bariani MV, Vafaei S, Omran MM, Yang Q, Madueke-Laveaux OS, Al-Hendy A. Prevention of Uterine Fibroids: molecular mechanisms and potential clinical application. J Endometr Uterine Disord. 2023 Mar; 1. PMID: 37637856; PMCID: PMC10451784.
      Citations: 4     
    52. Al-Hendy A, Yang Q, Dos Anjos LG, de Almeida BC, Baracat EC, Carvalho KC. Gene Expression Profile of Uterine Leiomyoma from Women Exposed to Different Air Pollution Levels in Metropolitan Cities of Sao Paulo, Brazil. Int J Mol Sci. 2023 Jan 26; 24(3). PMID: 36768749; PMCID: PMC9917088.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    53. Sefah N, Ndebele S, Prince L, Korasare E, Agbleke M, Nkansah A, Thompson H, Al-Hendy A, Agbleke AA. Uterine fibroids - Causes, impact, treatment, and lens to the African perspective. Front Pharmacol. 2022; 13:1045783. PMID: 36703761; PMCID: PMC9871264.
      Citations: 6     
    54. Siblini H, Al-Hendy A, Segars J, Taylor HS, Singh B, Flaminia A, Flores VA, Christman GM, Huang H, Johnson JJ, Zhang H, González F. Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women. Nutrients. 2023 Jan 09; 15(2). PMID: 36678191; PMCID: PMC9861948.
      Citations: 15     Fields:    Translation:Humans
    55. Elkafas H, Al-Hendy A, Ismail N, Walls M. Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders. Front Cell Infect Microbiol. 2022; 12:1059825. PMID: 36590579; PMCID: PMC9800796.
      Citations: 13     Fields:    Translation:Humans
    56. Yang Q, Falahati A, Khosh A, Mohammed H, Kang W, Bariani MV, Boyer TG, Al-Hendy A, Corachán A. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma. Cells. 2022 Nov 27; 11(23). PMID: 36497061; PMCID: PMC9735512.
      Citations: 8     Fields:    Translation:Humans
    57. Madueke-Laveaux OS, Ciebiera M, Al-Hendy A. GnRH analogs for the treatment of heavy menstrual bleeding associated with uterine fibroids. F S Rep. 2023 Jun; 4(2 Suppl):46-50. PMID: 37223760; PMCID: PMC10201292.
      Citations: 1     
    58. Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials. Am J Obstet Gynecol. 2023 03; 228(3):320.e1-320.e11. PMID: 36370871.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    59. Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas. Obstet Gynecol. 2022 12 01; 140(6):920-930. PMID: 36357960; PMCID: PMC9665945.
      Citations: 4     Fields:    Translation:Humans
    60. Dobroff AS, Yang Q, Al-Hendy A, de Almeida BC, Dos Anjos LG, Baracat EC, Carvalho KC. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines. 2022 Oct 13; 10(10). PMID: 36289829; PMCID: PMC9599831.
      Citations: 8     
    61. Taylor HS, Stewart EA, Bradley L, Marsh E, Archer D, Al-Hendy A, Petraglia F, Watts N, Gotteland JP, Bestel E, Terrill P, Loumaye E, Humberstone A, Garner E, Donnez J. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. Lancet. 2022 09 17; 400(10356):896-907. PMID: 36116480.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    62. Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG, Al-Hendy A. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022 07 13; 43(4):678-719. PMID: 34741454; PMCID: PMC9277653.
      Citations: 84     Fields:    Translation:Humans
    63. Yang Q, Bariani MV, Falahati A, Khosh A, Lastra RR, Siblini H, Boyer TG, Al-Hendy A. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma. Cells. 2022 07 10; 11(14). PMID: 35883603; PMCID: PMC9323884.
      Citations: 9     Fields:    Translation:Humans
    64. Banerjee S, Xu W, Chowdhury I, Driss A, Ali M, Yang Q, Al-Hendy A, Thompson WE. Human Myometrial and Uterine Fibroid Stem Cell-Derived Organoids for Intervening the Pathophysiology of Uterine Fibroid. Reprod Sci. 2022 09; 29(9):2607-2619. PMID: 35585291; PMCID: PMC9444830.
      Citations: 4     Fields:    Translation:HumansCells
    65. Navarro A, Bariani MV, Park HS, Zota AR, Al-Hendy A. Report of Exosomes Isolated from a Human Uterine Leiomyoma Cell Line and Their Impact on Endometrial Vascular Endothelial Cells. Pharmaceuticals (Basel). 2022 May 05; 15(5). PMID: 35631403; PMCID: PMC9143402.
      Citations: 3     
    66. Stewart EA, Lukes AS, Venturella R, Arjona Ferreira JC, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials. Obstet Gynecol. 2022 06 01; 139(6):1070-1081. PMID: 35675604.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    67. Park HS, Chugh RM, Pergande MR, Cetin E, Siblini H, Esfandyari S, Cologna SM, Al-Hendy A. Non-Cytokine Protein Profile of the Mesenchymal Stem Cell Secretome That Regulates the Androgen Production Pathway. Int J Mol Sci. 2022 Apr 22; 23(9). PMID: 35563028; PMCID: PMC9101816.
      Citations: 6     Fields:    Translation:HumansCells
    68. Zota AR, Chu MT, Marfori CQ, Khati NJ, Al-Hendy A, Taggart T. Adverse childhood experiences and health-related quality of life among women undergoing hysterectomy for uterine leiomyoma. Am J Obstet Gynecol. 2022 08; 227(2):351-353.e5. PMID: 35461825; PMCID: PMC10401515.
      Citations: 2     Fields:    Translation:Humans
    69. Yang Q, Al-Hendy A. The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer. Cells. 2022 03 29; 11(7). PMID: 35406713; PMCID: PMC8998012.
      Citations: 14     Fields:    Translation:Humans
    70. Mousaei Ghasroldasht M, Seok J, Park HS, Liakath Ali FB, Al-Hendy A. Stem Cell Therapy: From Idea to Clinical Practice. Int J Mol Sci. 2022 Mar 05; 23(5). PMID: 35269990; PMCID: PMC8911494.
      Citations: 48     Fields:    Translation:Humans
    71. Fadel HE, Al-Hendy A. Development of Obstetric Practice During the Early Islamic Era. Reprod Sci. 2022 09; 29(9):2587-2592. PMID: 35233736; PMCID: PMC9444839.
      Citations: 1     Fields:    Translation:Humans
    72. Wlodarczyk M, Nowicka G, Ciebiera M, Ali M, Yang Q, Al-Hendy A. Epigenetic Regulation in Uterine Fibroids-The Role of Ten-Eleven Translocation Enzymes and Their Potential Therapeutic Application. Int J Mol Sci. 2022 Feb 28; 23(5). PMID: 35269864; PMCID: PMC8910916.
      Citations: 4     Fields:    Translation:HumansCells
    73. Leyland N, Leonardi M, Murji A, Singh SS, Al-Hendy A, Bradley L. A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids. Reprod Sci. 2022 04; 29(4):1188-1196. PMID: 35178678; PMCID: PMC8853611.
      Citations: 7     Fields:    Translation:Humans
    74. Afrin S, Ali M, El Sabeh M, Yang Q, Al-Hendy A, Borahay MA. Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-ß3 and Wnt/ß-Catenin pathways. J Cell Mol Med. 2022 03; 26(5):1684-1698. PMID: 35118811; PMCID: PMC8899165.
      Citations: 7     Fields:    Translation:Humans
    75. Ali M, Chen HY, Chiang YF, Badary OA, Hsia SM, Al-Hendy A. An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Expert Opin Pharmacother. 2022 Mar; 23(4):421-429. PMID: 35068291; PMCID: PMC8866208.
      Citations: 4     Fields:    Translation:Humans
    76. Bateman NW, Tarney CM, Abulez TS, Hood BL, Conrads KA, Zhou M, Soltis AR, Teng PN, Jackson A, Tian C, Dalgard CL, Wilkerson MD, Kessler MD, Goecker Z, Loffredo J, Shriver CD, Hu H, Cote M, Parker GJ, Segars J, Al-Hendy A, Risinger JI, Phippen NT, Casablanca Y, Darcy KM, Maxwell GL, Conrads TP, O'Connor TD. Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. iScience. 2022 Jan 21; 25(1):103665. PMID: 35036865; PMCID: PMC8753123.
      Citations: 2     
    77. Madueke-Laveaux OS, Elsharoud A, Al-Hendy A. What We Know about the Long-Term Risks of Hysterectomy for Benign Indication-A Systematic Review. J Clin Med. 2021 Nov 16; 10(22). PMID: 34830617; PMCID: PMC8622061.
      Citations: 10     
    78. Cetin E, Siblini H, Al-Hendy A. What Is the Mechanism of Poor Endometrial Proliferation in Patients With Unexplained Infertility After Clomiphene Citrate Treatment? J Clin Endocrinol Metab. 2021 10 21; 106(11):e4776-e4777. PMID: 34192332; PMCID: PMC8530735.
      Citations: 1     Fields:    Translation:Humans
    79. Ali M, Raslan M, Ciebiera M, Zareba K, Al-Hendy A. Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids. Expert Opin Drug Saf. 2022 Apr; 21(4):477-486. PMID: 34612122; PMCID: PMC8940613.
      Citations: 8     Fields:    Translation:Humans
    80. Garcia N, Ulin M, Ali M, Al-Hendy A, Yang Q, Carvalho KC. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model. Reprod Sci. 2022 03; 29(3):781-790. PMID: 34642915; PMCID: PMC8863774.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    81. Stewart EA, Archer DF, Owens CD, Barnhart KT, Bradley LD, Feinberg EC, Gillispie-Bell V, Imudia AN, Liu R, Kim JH, Al-Hendy A. Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids. J Womens Health (Larchmt). 2022 05; 31(5):698-705. PMID: 34582715; PMCID: PMC9133968.
      Citations: 3     Fields:    Translation:Humans
    82. Afrin S, El Sabeh M, Islam MS, Miyashita-Ishiwata M, Malik M, Catherino WH, Akimzhanov AM, Boehning D, Yang Q, Al-Hendy A, Segars JH, Borahay MA. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation. Pharmacol Res. 2021 10; 172:105856. PMID: 34461224; PMCID: PMC8455458.
      Citations: 13     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    83. Chugh RM, Park HS, Esfandyari S, Elsharoud A, Ulin M, Al-Hendy A. Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2. Int J Mol Sci. 2021 Aug 25; 22(17). PMID: 34502090; PMCID: PMC8431467.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    84. Watts NB, Binkley N, Owens CD, Al-Hendy A, Puscheck EE, Shebley M, Schlaff WD, Simon JA. Bone Mineral Density Changes Associated With Pregnancy, Lactation, and Medical Treatments in Premenopausal Women and Effects Later in Life. J Womens Health (Larchmt). 2021 10; 30(10):1416-1430. PMID: 34435897.
      Citations: 6     Fields:    Translation:Humans
    85. Garcia N, Ulin M, Al-Hendy A, Yang Q. The Role of Hedgehog Pathway in Uterine Leiomyosarcoma. J Cell Sci Ther. 2021; 12(Suppl 5). PMID: 34956733; PMCID: PMC8697743.
      Citations: 1     
    86. Chugh RM, Park HS, El Andaloussi A, Elsharoud A, Esfandyari S, Ulin M, Bakir L, Aboalsoud A, Ali M, Ashour D, Igboeli P, Ismail N, McAllister J, Al-Hendy A. Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10. Stem Cell Res Ther. 2021 07 07; 12(1):388. PMID: 34233746; PMCID: PMC8261924.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    87. Al-Hendy A, Ku SY. Reproductive Tract Tissue/Organ Engineering and Regenerative Medicine for Reproduction. Reprod Sci. 2021 06; 28(6):1571-1572. PMID: 33905084.
      Citations:    Fields:    Translation:Humans
    88. Navarro A, Bariani MV, Yang Q, Al-Hendy A. Understanding the Impact of Uterine Fibroids on Human Endometrium Function. Front Cell Dev Biol. 2021; 9:633180. PMID: 34113609; PMCID: PMC8186666.
      Citations: 26     
    89. Ulin M, Cetin E, Hobeika E, Chugh RM, Park HS, Esfandyari S, Al-Hendy A. Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency. Reprod Sci. 2021 06; 28(6):1688-1696. PMID: 33956339; PMCID: PMC8144118.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    90. Bateman NW, Tarney CM, Abulez T, Soltis AR, Zhou M, Conrads K, Litzi T, Oliver J, Hood B, Driggers P, Viollet C, Dalgard C, Wilkerson M, Catherino W, Hamilton CA, Darcy KM, Casablanca Y, Al-Hendy A, Segars J, Conrads TP, Larry Maxwell G. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients. Sci Rep. 2021 04 30; 11(1):9371. PMID: 33931688; PMCID: PMC8087684.
      Citations: 7     Fields:    Translation:Humans
    91. Ciebiera M, Esfandyari S, Siblini H, Prince L, Elkafas H, Wojtyla C, Al-Hendy A, Ali M. Nutrition in Gynecological Diseases: Current Perspectives. Nutrients. 2021 Apr 02; 13(4). PMID: 33918317; PMCID: PMC8065992.
      Citations: 31     Fields:    Translation:Humans
    92. Park HS, Chugh RM, El Andaloussi A, Hobeika E, Esfandyari S, Elsharoud A, Ulin M, Garcia N, Bilal M, Al-Hendy A. Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model. Sci Rep. 2021 02 25; 11(1):4525. PMID: 33633319; PMCID: PMC7907146.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    93. Esfandyari S, Elkafas H, Chugh RM, Park HS, Navarro A, Al-Hendy A. Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy. Int J Mol Sci. 2021 Feb 22; 22(4). PMID: 33671587; PMCID: PMC7926632.
      Citations: 42     Fields:    Translation:HumansCells
    94. Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy. N Engl J Med. 2021 02 18; 384(7):630-642. PMID: 33596357; PMCID: PMC8262231.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    95. Park HS, Chugh RM, Elsharoud A, Ulin M, Esfandyari S, Aboalsoud A, Bakir L, Al-Hendy A. Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model. Cell Transplant. 2021 Jan-Dec; 30:963689720988502. PMID: 33593078; PMCID: PMC7894598.
      Citations: 11     Fields:    Translation:HumansAnimals
    96. Elkafas H, Badary O, Elmorsy E, Kamel R, Yang Q, Al-Hendy A. Endocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids. J Adv Pharm Res. 2021; 5(2):260-275. PMID: 34746367; PMCID: PMC8570385.
      Citations: 3     
    97. Garcia N, Al-Hendy A, Yang Q, Baracat EC, Carvalho KC. Targeting Hedgehog Pathway and DNA Methyltransferases in Uterine Leiomyosarcoma Cells. Cells. 2020 12 31; 10(1). PMID: 33396427; PMCID: PMC7824187.
      Citations: 17     Fields:    Translation:HumansCells
    98. Elsharoud A, Brakta S, Elhusseini H, Al-Hendy A. A presentation of ovarian fibrothecoma in a middle-aged female with recurrent massive ascites and postmenopausal bleeding: A case report. SAGE Open Med Case Rep. 2020; 8:2050313X20974222. PMID: 33425356; PMCID: PMC7758649.
      Citations:    
    99. Bariani MV, Rangaswamy R, Siblini H, Yang Q, Al-Hendy A, Zota AR. The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis. Curr Opin Endocrinol Diabetes Obes. 2020 12; 27(6):380-387. PMID: 33044243; PMCID: PMC8240765.
      Citations: 27     Fields:    Translation:HumansAnimalsPHPublic Health
    100. Leppert PC, Al-Hendy A, Baird DD, Bulun S, Catherino W, Dixon D, Ducharme M, Harmon QE, Jayes FL, Paul E, Perucho AM, Segars J, Stewart EA, Teixeira J, Tinelli A, Tschumperlin D, Zota AR, Simón C. Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020. F S Sci. 2021 02; 2(1):88-100. PMID: 34124698; PMCID: PMC8192074.
      Citations: 5     Fields:    Translation:Humans
    101. Ciebiera M, Ali M, Prince L, Zgliczynski S, Jakiel G, Al-Hendy A. The Significance of Measuring Vitamin D Serum Levels in Women with Uterine Fibroids. Reprod Sci. 2021 08; 28(8):2098-2109. PMID: 33108619; PMCID: PMC8262605.
      Citations: 8     Fields:    Translation:Humans
    102. Garcia N, Ulin M, Al-Hendy A, Yang Q. The Role of Hedgehog Pathway in Female Cancers. J Cancer Sci Clin Ther. 2020; 4(4):487-498. PMID: 33179013; PMCID: PMC7654982.
      Citations: 9     
    103. Esfandyari S, Chugh RM, Park HS, Hobeika E, Ulin M, Al-Hendy A. Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility. Cells. 2020 10 08; 9(10). PMID: 33050021; PMCID: PMC7599919.
      Citations: 41     Fields:    Translation:HumansCells
    104. Cetin E, Al-Hendy A, Ciebiera M. Non-hormonal mediators of uterine fibroid growth. Curr Opin Obstet Gynecol. 2020 10; 32(5):361-370. PMID: 32739973; PMCID: PMC8314923.
      Citations: 9     Fields:    Translation:HumansCells
    105. Ciebiera M, Ali M, Zgliczynska M, Skrzypczak M, Al-Hendy A. Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance. Int J Mol Sci. 2020 Aug 01; 21(15). PMID: 32752274; PMCID: PMC7432695.
      Citations: 12     Fields:    Translation:Humans
    106. Al-Hendy A, Bradley L, Owens CD, Wang H, Barnhart KT, Feinberg E, Schlaff WD, Puscheck EE, Wang A, Gillispie V, Hurtado S, Muneyyirci-Delale O, Archer DF, Carr BR, Simon JA, Stewart EA. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids. Am J Obstet Gynecol. 2021 01; 224(1):72.e1-72.e50. PMID: 32702363; PMCID: PMC8800453.
      Citations: 10     Fields:    
    107. Igboeli P, El Andaloussi A, Sheikh U, Takala H, ElSharoud A, McHugh A, Gavrilova-Jordan L, Levy S, Al-Hendy A. Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature. J Med Case Rep. 2020 Jul 18; 14(1):108. PMID: 32680541; PMCID: PMC7368722.
      Citations: 33     Fields:    Translation:HumansCells
    108. Elkafas H, Ali M, Elmorsy E, Kamel R, Thompson WE, Badary O, Al-Hendy A, Yang Q. Vitamin D3 Ameliorates DNA Damage Caused by Developmental Exposure to Endocrine Disruptors in the Uterine Myometrial Stem Cells of Eker Rats. Cells. 2020 06 12; 9(6). PMID: 32545544; PMCID: PMC7349254.
      Citations: 24     Fields:    Translation:AnimalsCells
    109. Ali M, Esfandyari S, Al-Hendy A. Evolving role of microRNAs in uterine fibroid pathogenesis: filling the gap! Fertil Steril. 2020 06; 113(6):1167-1168. PMID: 32482253.
      Citations: 9     Fields:    Translation:HumansCells
    110. Simon JA, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR, Dayspring T, Feinberg EC, Gillispie V, Hurtado S, Kim J, Liu R, Owens CD, Muneyyirci-Delale O, Wang A, Watts NB, Schlaff WD. Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstet Gynecol. 2020 06; 135(6):1313-1326. PMID: 32459423; PMCID: PMC7253187.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    111. Ciebiera M, Ali M, Prince L, Jackson-Bey T, Atabiekov I, Zgliczynski S, Al-Hendy A. The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids. J Clin Med. 2020 May 14; 9(5). PMID: 32423112; PMCID: PMC7290481.
      Citations: 14     
    112. Ali M, Shahin SM, Sabri NA, Al-Hendy A, Yang Q. Activation of ß-Catenin Signaling and its Crosstalk With Estrogen and Histone Deacetylases in Human Uterine Fibroids. J Clin Endocrinol Metab. 2020 04 01; 105(4). PMID: 31761932; PMCID: PMC7064306.
      Citations: 23     Fields:    Translation:HumansCells
    113. Small B, Millard CEF, Kisanga EP, Burman A, Anam A, Flannery C, Al-Hendy A, Whirledge S. The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor. J Clin Endocrinol Metab. 2020 03 01; 105(3). PMID: 31665442; PMCID: PMC7112983.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    114. Ulin M, Ali M, Chaudhry ZT, Al-Hendy A, Yang Q. Uterine fibroids in menopause and perimenopause. Menopause. 2020 02; 27(2):238-242. PMID: 31834160; PMCID: PMC6994343.
      Citations: 29     Fields:    Translation:Humans
    115. Schlaff WD, Ackerman RT, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR, Feinberg EC, Hurtado SM, Kim J, Liu R, Mabey RG, Owens CD, Poindexter A, Puscheck EE, Rodriguez-Ginorio H, Simon JA, Soliman AM, Stewart EA, Watts NB, Muneyyirci-Delale O. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids. N Engl J Med. 2020 01 23; 382(4):328-340. PMID: 31971678.
      Citations: 58     Fields:    Translation:HumansCTClinical Trials
    116. Shalaby S, Khater M, Laknaur A, Arbab A, Al-Hendy A. Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma. Reprod Sci. 2020 02; 27(2):644-654. PMID: 31925772; PMCID: PMC7539812.
      Citations: 6     Fields:    Translation:HumansCells
    117. El Andaloussi A, Al-Hendy A, Ismail N, Boyer TG, Halder SK. Introduction of Somatic Mutation in MED12 Induces Wnt4/ß-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell. Reprod Sci. 2020 03; 27(3):823-832. PMID: 32046450; PMCID: PMC7539814.
      Citations: 27     Fields:    Translation:HumansCells
    118. Ku SY, Al-Hendy A. Vision 20/20 for the Second Leap of Reproductive Sciences. Reprod Sci. 2020 01; 27(1):1-2. PMID: 32030671; PMCID: PMC7104448.
      Citations:    Fields:    Translation:Humans
    119. Takala H, Al-Hendy A, Yang Q. Neurotrimin: a novel neural cell adhesion molecule correlating with uterine fibroid phenotype. Fertil Steril. 2020 01; 113(1):83-84. PMID: 32033733.
      Citations:    Fields:    Translation:Humans
    120. Ali M, Prince L, Al-Hendy A. Vitamin D and uterine fibroids: preclinical evidence is in; time for an overdue clinical study! Fertil Steril. 2020 01; 113(1):89-90. PMID: 32033736.
      Citations: 8     Fields:    Translation:HumansAnimals
    121. Takala H, Yang Q, El Razek AMA, Ali M, Al-Hendy A. Alcohol Consumption and Risk of Uterine Fibroids. Curr Mol Med. 2020; 20(4):247-258. PMID: 31612831.
      Citations: 7     Fields:    Translation:Humans
    122. Park HS, Ashour D, Elsharoud A, Chugh RM, Ismail N, El Andaloussi A, Al-Hendy A. Towards Cell free Therapy of Premature Ovarian Insufficiency: Human Bone Marrow Mesenchymal Stem Cells Secretome Enhances Angiogenesis in Human Ovarian Microvascular Endothelial Cells. HSOA J Stem Cells Res Dev Ther. 2019; 5(2). PMID: 32494757; PMCID: PMC7269190.
      Citations: 14     
    123. Igboeli P, Walker W, McHugh A, Sultan A, Al-Hendy A. Burden of Uterine Fibroids: An African Perspective, A Call for Action and Opportunity for Intervention. Curr Opin Gynecol Obstet. 2019; 2(1):287-294. PMID: 32647835; PMCID: PMC7344264.
      Citations: 8     
    124. Omar M, Laknaur A, Al-Hendy A, Yang Q. Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids. BMC Womens Health. 2019 07 09; 19(1):92. PMID: 31288815; PMCID: PMC6617862.
      Citations: 14     Fields:    Translation:Humans
    125. Cao T, Jiang Y, Wang Z, Zhang N, Al-Hendy A, Mamillapalli R, Kallen AN, Kodaman P, Taylor HS, Li D, Huang Y. H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas. Oncogene. 2019 07; 38(27):5356-5366. PMID: 31089260; PMCID: PMC6755985.
      Citations: 39     Fields:    Translation:HumansCells
    126. Ulin M, Al-Hendy A, Yang Q. Targeting the transforming growth factor-ß pathway: a novel mechanism of ulipristal acetate action against uterine fibroids. Fertil Steril. 2019 04; 111(4):683-684. PMID: 30929728.
      Citations: 1     Fields:    Translation:Humans
    127. Mohamed SA, Shalaby S, Brakta S, Elam L, Elsharoud A, Al-Hendy A. Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency. Biomedicines. 2019 Jan 18; 7(1). PMID: 30669278; PMCID: PMC6466426.
      Citations: 29     
    128. Ali M, Al-Hendy A, Yang Q. Vitamin D, a promising natural compound with anti-uterine fibroid characteristics. Fertil Steril. 2019 02; 111(2):268-269. PMID: 30598168.
      Citations: 6     Fields:    Translation:Humans
    129. Ali M, Shahin SM, Sabri NA, Al-Hendy A, Yang Q. 1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids. Reprod Sci. 2019 06; 26(6):812-828. PMID: 30514160; PMCID: PMC6728560.
      Citations: 18     Fields:    Translation:HumansCells
    130. Ali M, Jackson-Bey T, Al-Hendy A. Simvastatin and uterine fibroids: opportunity for a novel therapeutic option. Fertil Steril. 2018 12; 110(7):1272-1273. PMID: 30503124; PMCID: PMC7909745.
      Citations: 1     Fields:    Translation:HumansCells
    131. Brakta S, Mas A, Al-Hendy A. The ontogeny of myometrial stem cells in OCT4-GFP transgenic mouse model. Stem Cell Res Ther. 2018 11 29; 9(1):333. PMID: 30486855; PMCID: PMC6264618.
      Citations: 5     Fields:    Translation:AnimalsCells
    132. Ali M, Shahin SM, Sabri NA, Al-Hendy A, Yang Q. Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment. Acta Pharmacol Sin. 2019 Jul; 40(7):957-970. PMID: 30478352; PMCID: PMC6786389.
      Citations: 28     Fields:    Translation:HumansCells
    133. Park MJ, Shen H, Kim NH, Gao F, Failor C, Knudtson JF, McLaughlin J, Halder SK, Heikkinen TA, Vahteristo P, Al-Hendy A, Schenken RS, Boyer TG. Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas. J Clin Endocrinol Metab. 2018 11 01; 103(11):4283-4292. PMID: 30099503; PMCID: PMC6194812.
      Citations: 17     Fields:    Translation:Humans
    134. Atabiekov I, Hobeika E, Sheikh U, El Andaloussi A, Al-Hendy A. The Role of Gene Therapy in Premature Ovarian Insufficiency Management. Biomedicines. 2018 Nov 01; 6(4). PMID: 30388808; PMCID: PMC6316312.
      Citations: 9     
    135. Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 2018 11; 132(5):1252-1264. PMID: 30303923; PMCID: PMC7963450.
      Citations: 18     Fields:    Translation:Humans
    136. Prusinski Fernung LE, Yang Q, Sakamuro D, Kumari A, Mas A, Al-Hendy A. Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells. Biol Reprod. 2018 10 01; 99(4):735-748. PMID: 29688260; PMCID: PMC6203880.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    137. Marsh EE, Al-Hendy A, Kappus D, Galitsky A, Stewart EA, Kerolous M. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. J Womens Health (Larchmt). 2018 11; 27(11):1359-1367. PMID: 30230950; PMCID: PMC6247381.
      Citations: 69     Fields:    Translation:Humans
    138. Yang Q, Ali M, El Andaloussi A, Al-Hendy A. The emerging spectrum of early life exposure-related inflammation and epigenetic therapy. Cancer Stud Mol Med. 2018 Nov; 4(1):13-23. PMID: 30474062; PMCID: PMC6247815.
      Citations: 5     
    139. El Andaloussi A, Igboeli P, Amer A, Al-Hendy A. Intravenous Infusion of Nucleated Peripheral Blood Cells Restores Fertility in Mice with Chemotherapy-Induced Premature Ovarian Failure. Biomedicines. 2018 Sep 15; 6(3). PMID: 30223591; PMCID: PMC6163893.
      Citations: 2     
    140. Elhusseini H, Elkafas H, Abdelaziz M, Halder S, Atabiekov I, Eziba N, Ismail N, El Andaloussi A, Al-Hendy A. Diet-induced vitamin D deficiency triggers inflammation and DNA damage profile in murine myometrium. Int J Womens Health. 2018; 10:503-514. PMID: 30214319; PMCID: PMC6120572.
      Citations: 18     
    141. Ali M, Al-Hendy A. Uterine fibroid therapy: the pharmacokinetic considerations. Expert Opin Drug Metab Toxicol. 2018 Sep; 14(9):887-889. PMID: 30058386.
      Citations: 4     Fields:    Translation:Humans
    142. Prusinski Fernung LE, Jones K, Mas A, Kleven D, Waller JL, Al-Hendy A. Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment. Am J Pathol. 2018 10; 188(10):2293-2306. PMID: 30075150; PMCID: PMC6168956.
      Citations: 8     Fields:    Translation:HumansCells
    143. Prusinski Fernung LE, Al-Hendy A, Yang Q. A Preliminary Study: Human Fibroid Stro-1+/CD44+ Stem Cells Isolated From Uterine Fibroids Demonstrate Decreased DNA Repair and Genomic Integrity Compared to Adjacent Myometrial Stro-1+/CD44+ Cells. Reprod Sci. 2019 05; 26(5):619-638. PMID: 29954254; PMCID: PMC6728578.
      Citations: 17     Fields:    Translation:HumansCells
    144. Habib S, El Andaloussi A, Elmasry K, Handoussa A, Azab M, Elsawey A, Al-Hendy A, Ismail N. PDL-1 Blockade Prevents T Cell Exhaustion, Inhibits Autophagy, and Promotes Clearance of Leishmania donovani. Infect Immun. 2018 06; 86(6). PMID: 29610255; PMCID: PMC5964517.
      Citations: 26     Fields:    Translation:AnimalsCells
    145. Yang Q, Al-Hendy A. The Emerging Role of p27 in Development of Diseases. Cancer Stud Mol Med. 2018 Nov; 4(1):e1-e3. PMID: 30474063; PMCID: PMC6247914.
      Citations: 5     
    146. Yang Q, Al-Hendy A. Non-coding RNAs: an important regulatory mechanism in pathogenesis of uterine fibroids. Fertil Steril. 2018 05; 109(5):802-803. PMID: 29778379; PMCID: PMC7990164.
      Citations: 5     Fields:    Translation:Humans
    147. Simon JA, Catherino W, Segars JH, Blakesley RE, Chan A, Sniukiene V, Al-Hendy A. Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 2018 03; 131(3):431-439. PMID: 29420395; PMCID: PMC7968372.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    148. Park MJ, Shen H, Spaeth JM, Tolvanen JH, Failor C, Knudtson JF, McLaughlin J, Halder SK, Yang Q, Bulun SE, Al-Hendy A, Schenken RS, Aaltonen LA, Boyer TG. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19. J Biol Chem. 2018 03 30; 293(13):4870-4882. PMID: 29440396; PMCID: PMC5880139.
      Citations: 31     Fields:    Translation:HumansCells
    149. Ali M, Chaudhry ZT, Al-Hendy A. Successes and failures of uterine leiomyoma drug discovery. Expert Opin Drug Discov. 2018 02; 13(2):169-177. PMID: 29254389.
      Citations: 27     Fields:    Translation:HumansAnimals
    150. Segars JH, Al-Hendy A. Uterine Leiomyoma: New Perspectives on an Old Disease. Semin Reprod Med. 2017 11; 35(6):471-472. PMID: 29100233.
      Citations: 6     Fields:    Translation:Humans
    151. Al-Hendy A, Myers ER, Stewart E. Uterine Fibroids: Burden and Unmet Medical Need. Semin Reprod Med. 2017 11; 35(6):473-480. PMID: 29100234; PMCID: PMC6193285.
      Citations: 82     Fields:    Translation:Humans
    152. El Andaloussi A, Chaudhry Z, Al-Hendy A, Ismail N. Uterine Fibroids: Bridging Genomic Defects and Chronic Inflammation. Semin Reprod Med. 2017 11; 35(6):494-498. PMID: 29100237.
      Citations: 10     Fields:    Translation:Humans
    153. Elkafas H, Qiwei Y, Al-Hendy A. Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells. Semin Reprod Med. 2017 11; 35(6):481-486. PMID: 29100235.
      Citations: 15     Fields:    Translation:HumansCells
    154. Abdelaziz M, Eziba N, Sharma S, Kleven D, Al-Hendy A. Cervical superficial myofibroblastoma: Case report and review of the literature. SAGE Open Med Case Rep. 2017; 5:2050313X17726936. PMID: 28904795; PMCID: PMC5588789.
      Citations: 3     
    155. Ali M, Al-Hendy A. Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids. Biol Reprod. 2017 Sep 01; 97(3):337-352. PMID: 29025038; PMCID: PMC5803778.
      Citations: 26     Fields:    Translation:Humans
    156. Andaloussi AE, Habib S, Soylemes G, Laknaur A, Elhusseini H, Al-Hendy A, Ismail N. Defective expression of ATG4D abrogates autophagy and promotes growth in human uterine fibroids. Cell Death Discov. 2017; 3:17041. PMID: 28815060; PMCID: PMC5554887.
      Citations: 18     
    157. Mohamed SA, El Andaloussi A, Al-Hendy A, Menon R, Behnia F, Schulkin J, Power ML. Vitamin D and corticotropin-releasing hormone in term and preterm birth: potential contributions to preterm labor and birth outcome. J Matern Fetal Neonatal Med. 2018 Nov; 31(21):2911-2917. PMID: 28780891.
      Citations: 4     Fields:    Translation:HumansCells
    158. Fletcher NM, Abusamaan MS, Memaj I, Saed MG, Al-Hendy A, Diamond MP, Saed GM. Oxidative stress: a key regulator of leiomyoma cell survival. Fertil Steril. 2017 06; 107(6):1387-1394.e1. PMID: 28483502.
      Citations: 12     Fields:    Translation:HumansCells
    159. Mohamed SA, Shalaby SM, Abdelaziz M, Brakta S, Hill WD, Ismail N, Al-Hendy A. Human Mesenchymal Stem Cells Partially Reverse Infertility in Chemotherapy-Induced Ovarian Failure. Reprod Sci. 2018 01; 25(1):51-63. PMID: 28460567; PMCID: PMC6344979.
      Citations: 68     Fields:    Translation:HumansAnimalsCells
    160. Al-Hendy A, Laknaur A, Diamond MP, Ismail N, Boyer TG, Halder SK. Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/ß-Catenin Signaling Pathway. Endocrinology. 2017 03 01; 158(3):592-603. PMID: 27967206; PMCID: PMC5460776.
      Citations: 44     Fields:    Translation:HumansCells
    161. Mas A, Prusinski L, Yang Q, Diaz-Gimeno P, Stone L, Diamond MP, Al-Hendy A, Simón C. Role of Stro1+/CD44+ stem cells in myometrial physiology and uterine remodeling during pregnancy. Biol Reprod. 2017 01 01; 96(1):70-80. PMID: 28395335; PMCID: PMC5803774.
      Citations: 10     Fields:    Translation:AnimalsCells
    162. Yang Q, Al-Hendy A. Developmental Environmental Exposure Alters the Epigenetic Features of Myometrial Stem Cells. Gynecol Obstet Res. 2016 Dec; 3(2):e1-e4. PMID: 28626795; PMCID: PMC5473610.
      Citations: 6     
    163. Borahay MA, Asoglu MR, Mas A, Adam S, Kilic GS, Al-Hendy A. Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications. Reprod Sci. 2017 09; 24(9):1235-1244. PMID: 27872195; PMCID: PMC6344829.
      Citations: 54     Fields:    Translation:HumansAnimalsCells
    164. Mas A, Stone L, O'Connor PM, Yang Q, Kleven D, Simon C, Walker CL, Al-Hendy A. Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis. Stem Cells. 2017 03; 35(3):666-678. PMID: 27739139.
      Citations: 30     Fields:    Translation:HumansAnimalsPHPublic Health
    165. Chuang TY, Min J, Wu HL, McCrary C, Layman LC, Diamond MP, Azziz R, Al-Hendy A, Chen YH. Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1. Reprod Sci. 2017 07; 24(7):1005-1013. PMID: 27799459.
      Citations: 5     Fields:    Translation:AnimalsCells
    166. Halder S, Al-Hendy A. Hypovitaminosis D and high serum transforming growth factor beta-3: important biomarkers for uterine fibroids risk. Fertil Steril. 2016 12; 106(7):1648-1649. PMID: 27793369; PMCID: PMC7344336.
      Citations: 14     Fields:    Translation:Humans
    167. Atta HM, Al-Hendy AA, Abdel Raheim SR, Abdel-Ghany H, Nasif KA, Abdellah AM, Zenhom NM, Kamel HS. Modified Adenovirus Reduces De Novo Peritoneal Adhesions in Rats and Limits Off-Target Transfection. Role of EZH2 in Adhesion Formation. J Invest Surg. 2017 Apr; 30(2):78-87. PMID: 27690696.
      Citations:    Fields:    Translation:HumansAnimalsCells
    168. Latif E, Adam S, Rungruang B, Al-Hendy A, Diamond MP, Rotem E, Cannell J, Browne PC. Use of uterine artery embolization to prevent peripartum hemorrhage of placental abruption with fetal demise & severe DIC. J Neonatal Perinatal Med. 2016 Sep 16; 9(3):325-31. PMID: 27589544.
      Citations: 1     Fields:    Translation:Humans
    169. Mohamed SA, Al-Hendy A, Schulkin J, Power ML. Opinions and Practice of US-Based Obstetrician-Gynecologists regarding Vitamin D Screening and Supplementation of Pregnant Women. J Pregnancy. 2016; 2016:1454707. PMID: 27648304; PMCID: PMC5014971.
      Citations: 3     Fields:    Translation:Humans
    170. Katz TA, Yang Q, Walker CL, Al-Hendy A, Treviño LS. Endocrine-disrupting chemicals and uterine fibroids. Fertil Steril. 2016 09 15; 106(4):967-77. PMID: 27553264; PMCID: PMC5051569.
      Citations: 27     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    171. Othman ER, Elgamal DA, Refaiy AM, Abdelaal II, Abdel-Mola AF, Al-Hendy A. Identification and potential role of telocytes in human uterine leiomyoma. Contracept Reprod Med. 2016; 1:12. PMID: 29201401; PMCID: PMC5693520.
      Citations: 6     
    172. Prusinski L, Al-Hendy A, Yang Q. Developmental exposure to endocrine disrupting chemicals alters the epigenome: Identification of reprogrammed targets. Gynecol Obstet Res. 2016 Jul; 3(1):1-6. PMID: 27478869; PMCID: PMC4966680.
      Citations: 19     
    173. Yang Q, Diamond MP, Al-Hendy A. Converting of Myometrial Stem Cells to Tumor-Initiating Cells: Mechanism of Uterine Fibroid Development. Cell Stem Cells Regen Med. 2016 Apr; 2(1). PMID: 28042616; PMCID: PMC5199021.
      Citations: 9     
    174. Yang Q, Laknaur A, Elam L, Ismail N, Gavrilova-Jordan L, Lue J, Diamond MP, Al-Hendy A. Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids. Reprod Sci. 2016 10; 23(10):1314-25. PMID: 27036951; PMCID: PMC5933176.
      Citations: 11     Fields:    Translation:HumansCells
    175. Shalaby SM, Khater MK, Perucho AM, Mohamed SA, Helwa I, Laknaur A, Lebedyeva I, Liu Y, Diamond MP, Al-Hendy AA. Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells. Fertil Steril. 2016 06; 105(6):1638-1648.e8. PMID: 27020169; PMCID: PMC4971775.
      Citations: 16     Fields:    Translation:HumansCells
    176. Yang Q, Diamond MP, Al-Hendy A. Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic Regulation. Front Pharmacol. 2016; 7:40. PMID: 26973527; PMCID: PMC4772696.
      Citations: 28     
    177. Othman ER, Hussein M, Abdelaal II, Sayed AA, Fetih AN, Al-Hendy A, Hornung D. Soluble tumor necrosis factor-alpha receptors in the serum of endometriosis patients. Eur J Obstet Gynecol Reprod Biol. 2016 May; 200:1-5. PMID: 26963895.
      Citations: 2     Fields:    Translation:Humans
    178. Yang Q, Nair S, Laknaur A, Ismail N, Diamond MP, Al-Hendy A. The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids. Biol Reprod. 2016 Mar; 94(3):69. PMID: 26888970; PMCID: PMC4829092.
      Citations: 24     Fields:    Translation:HumansCells
    179. Abdelaziz M, Sherif L, ElKhiary M, Nair S, Shalaby S, Mohamed S, Eziba N, El-Lakany M, Curiel D, Ismail N, Diamond MP, Al-Hendy A. Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for In Vivo Gene Therapy of Uterine Leiomyoma. Reprod Sci. 2016 Apr; 23(4):464-74. PMID: 26884457; PMCID: PMC5933189.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    180. Othman ER, Curiel DT, Hussein M, Abdelaal II, Fetih AN, Al-Hendy A. Enhancing Adenoviral-Mediated Gene Transfer and Expression to Endometrial Cells. Reprod Sci. 2016 08; 23(8):1109-15. PMID: 26865542.
      Citations:    Fields:    Translation:HumansCells
    181. Mohamed SA, Al-Hendy A, Ghamande S, Chaffin J, Browne P. Atypical Presentations of Molar Pregnancy: Diagnostic Roles of Imaging, ß-Human Chorionic Gonadotropin Measurement, and p57 Immunostaining. J Ultrasound Med. 2016 Mar; 35(3):643-9. PMID: 26860483.
      Citations:    Fields:    Translation:Humans
    182. Yang Q, Diamond MP, Al-Hendy A. The emerging role of extracellular vesicle-derived miRNAs: implication in cancer progression and stem cell related diseases. J Clin Epigenet. 2016; 2(1). PMID: 27099870; PMCID: PMC4834835.
      Citations: 33     
    183. Al-Hendy A, Diamond MP, Boyer TG, Halder SK. Vitamin D3 Inhibits Wnt/ß-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells. J Clin Endocrinol Metab. 2016 04; 101(4):1542-51. PMID: 26820714; PMCID: PMC4880168.
      Citations: 39     Fields:    Translation:HumansCells
    184. Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol. 2016 Mar-Apr; 23(3):303-8. PMID: 26773577.
      Citations: 3     Fields:    
    185. Laknaur A, Foster TL, Bobb LE, Ramesh A, Ladson GM, Hood DB, Al-Hendy A, Thota C. Altered expression of histone deacetylases, inflammatory cytokines and contractile-associated factors in uterine myometrium of Long Evans rats gestationally exposed to benzo[a]pyrene. J Appl Toxicol. 2016 Jun; 36(6):827-35. PMID: 26358852; PMCID: PMC5404737.
      Citations: 5     Fields:    Translation:Animals
    186. Brakta S, Diamond JS, Al-Hendy A, Diamond MP, Halder SK. Role of vitamin D in uterine fibroid biology. Fertil Steril. 2015 Sep; 104(3):698-706. PMID: 26079694; PMCID: PMC4561014.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    187. Mas A, Nair S, Laknaur A, Diamond MP, Al-Hendy A, Simón C. Stro-1/CD44 as putative human myometrial and fibroid stem cell markers. Fertil Steril. 2015 Jul; 104(1):225-34.e3. PMID: 25989979; PMCID: PMC4490118.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    188. Yang Q, Mas A, Diamond MP, Al-Hendy A. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development. Reprod Sci. 2016 Feb; 23(2):163-75. PMID: 25922306; PMCID: PMC5933172.
      Citations: 64     Fields:    Translation:HumansCells
    189. Borahay MA, Al-Hendy A, Kilic GS, Boehning D. Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy. Mol Med. 2015 Apr 13; 21:242-56. PMID: 25879625; PMCID: PMC4503645.
      Citations: 66     Fields:    Translation:HumansAnimalsCells
    190. Borahay MA, Vincent K, Motamedi M, Sbrana E, Kilic GS, Al-Hendy A, Boehning D. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study. Am J Obstet Gynecol. 2015 Aug; 213(2):196.e1-8. PMID: 25840272; PMCID: PMC4519389.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    191. Nothnick WB, Al-Hendy A, Lue JR. Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise. J Minim Invasive Gynecol. 2015 Jul-Aug; 22(5):719-26. PMID: 25757811; PMCID: PMC4489990.
      Citations: 10     Fields:    Translation:Humans
    192. Wu HL, Chuang TY, Al-Hendy A, Diamond MP, Azziz R, Chen YH. Berberine inhibits the proliferation of human uterine leiomyoma cells. Fertil Steril. 2015 Apr; 103(4):1098-106. PMID: 25682924.
      Citations: 13     Fields:    Translation:HumansCells
    193. Al-Hendy A, Diamond MP, El-Sohemy A, Halder SK. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. J Clin Endocrinol Metab. 2015 Apr; 100(4):E572-82. PMID: 25625804; PMCID: PMC4399292.
      Citations: 38     Fields:    Translation:HumansCells
    194. Atta H, El-Rehany M, Hammam O, Abdel-Ghany H, Ramzy M, Roderfeld M, Roeb E, Al-Hendy A, Raheim SA, Allam H, Marey H. Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One. 2014; 9(11):e112384. PMID: 25380300; PMCID: PMC4224431.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    195. Borahay MA, Kilic GS, Yallampalli C, Snyder RR, Hankins GD, Al-Hendy A, Boehning D. Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells. J Biol Chem. 2014 Dec 19; 289(51):35075-86. PMID: 25359773; PMCID: PMC4271198.
      Citations: 40     Fields:    Translation:HumansCells
    196. Halder SK, Laknaur A, Miller J, Layman LC, Diamond M, Al-Hendy A. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids. Mol Genet Genomics. 2015 Apr; 290(2):505-11. PMID: 25325994; PMCID: PMC4682355.
      Citations: 38     Fields:    Translation:Humans
    197. Moghazy D, Sharan C, Nair M, Rackauskas C, Burnette R, Diamond M, Al-Hendy O, Al-Hendy A. Sertoli-Leydig cell tumor with unique nail findings in a post-menopausal woman: a case report and literature review. J Ovarian Res. 2014 Aug 28; 7:83. PMID: 25296983; PMCID: PMC4244065.
      Citations: 3     Fields:    Translation:Humans
    198. Stilley JA, Christensen DE, Dahlem KB, Guan R, Santillan DA, England SK, Al-Hendy A, Kirby PA, Segaloff DL. FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice. Biol Reprod. 2014 Sep; 91(3):74. PMID: 25100706; PMCID: PMC4435062.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    199. Al-Hendy A, Badr M. Can vitamin D reduce the risk of uterine fibroids? Womens Health (Lond). 2014 Jul; 10(4):353-8. PMID: 25259897; PMCID: PMC4209245.
      Citations: 14     Fields:    Translation:HumansAnimals
    200. Zhang D, Rajaratnam V, Al-Hendy O, Halder S, Al-Hendy A. Green tea extract inhibition of human leiomyoma cell proliferation is mediated via catechol-O-methyltransferase. Gynecol Obstet Invest. 2014; 78(2):109-18. PMID: 24942317.
      Citations: 11     Fields:    Translation:HumansCells
    201. Halder SK, Sharan C, Al-Hendy O, Al-Hendy A. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids. Reprod Sci. 2014 Sep; 21(9):1108-19. PMID: 24925855; PMCID: PMC4212343.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    202. Moghazy D, Al-Hendy O, Al-Hendy A. Krukenberg tumor presenting as back pain and a positive urine pregnancy test: a case report and literature review. J Ovarian Res. 2014 Apr 07; 7:36. PMID: 24708577; PMCID: PMC4234994.
      Citations: 4     Fields:    Translation:Humans
    203. Fletcher NM, Saed MG, Abuanzeh S, Abu-Soud HM, Al-Hendy A, Diamond MP, Saed GM. Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma. Reprod Sci. 2014 Sep; 21(9):1145-52. PMID: 24520084; PMCID: PMC5933080.
      Citations: 11     Fields:    Translation:HumansCells
    204. Mohamed SA, Thota C, Browne PC, Diamond MP, Al-Hendy A. Why is Preterm Birth Stubbornly Higher in African-Americans? Obstet Gynecol Int J. 2014; 1(3). PMID: 25905109; PMCID: PMC4402979.
      Citations: 8     
    205. Halder SK, Osteen KG, Al-Hendy A. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod. 2013 Dec; 89(6):150. PMID: 24174578; PMCID: PMC4076359.
      Citations: 50     Fields:    Translation:HumansCells
    206. Thota C, Laknaur A, Farmer T, Ladson G, Al-Hendy A, Ismail N. Vitamin D regulates contractile profile in human uterine myometrial cells via NF-?B pathway. Am J Obstet Gynecol. 2014 Apr; 210(4):347.e1-347.e10. PMID: 24262718; PMCID: PMC3972355.
      Citations: 26     Fields:    Translation:HumansCells
    207. Nair S, Nguyen H, Salama S, Al-Hendy A. Obesity and the Endometrium: Adipocyte-Secreted Proinflammatory TNF a Cytokine Enhances the Proliferation of Human Endometrial Glandular Cells. Obstet Gynecol Int. 2013; 2013:368543. PMID: 24288542; PMCID: PMC3832969.
      Citations: 10     
    208. Catherino WH, Eltoukhi HM, Al-Hendy A. Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma. Semin Reprod Med. 2013 Sep; 31(5):370-9. PMID: 23934698; PMCID: PMC4170830.
      Citations: 53     Fields:    Translation:HumansAnimals
    209. Roshdy E, Rajaratnam V, Maitra S, Sabry M, Allah AS, Al-Hendy A. Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study. Int J Womens Health. 2013; 5:477-86. PMID: 23950663; PMCID: PMC3742155.
      Citations: 38     
    210. Nair S, Saed GM, Atta HM, Rajaratnam V, Diamond MP, Curiel DT, Al-Hendy A. Towards gene therapy of postoperative adhesions: fiber and transcriptional modifications enhance adenovirus targeting towards human adhesion cells. Gynecol Obstet Invest. 2013; 76(2):119-24. PMID: 23920223; PMCID: PMC4172483.
      Citations: 8     Fields:    Translation:HumansCells
    211. Nair S, Curiel DT, Rajaratnam V, Thota C, Al-Hendy A. Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas. Hum Reprod. 2013 Sep; 28(9):2398-406. PMID: 23820419; PMCID: PMC3748860.
      Citations: 11     Fields:    Translation:HumansCells
    212. Fletcher NM, Saed MG, Abu-Soud HM, Al-Hendy A, Diamond MP, Saed GM. Uterine fibroids are characterized by an impaired antioxidant cellular system: potential role of hypoxia in the pathophysiology of uterine fibroids. J Assist Reprod Genet. 2013 Jul; 30(7):969-74. PMID: 23812845; PMCID: PMC3725220.
      Citations: 17     Fields:    Translation:HumansCells
    213. Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013 Sep; 28(9):2407-16. PMID: 23814095; PMCID: PMC3748859.
      Citations: 49     Fields:    Translation:HumansCells
    214. Thota C, Menon R, Fortunato SJ, Brou L, Lee JE, Al-Hendy A. 1,25-Dihydroxyvitamin D deficiency is associated with preterm birth in African American and Caucasian women. Reprod Sci. 2014 Feb; 21(2):244-50. PMID: 23793474; PMCID: PMC3879992.
      Citations: 20     Fields:    Translation:Humans
    215. Ravella K, Al-Hendy A, Sharan C, Hale AB, Channon KM, Srinivasan S, Gangula PR. Chronic estrogen deficiency causes gastroparesis by altering neuronal nitric oxide synthase function. Dig Dis Sci. 2013 Jun; 58(6):1507-15. PMID: 23504347; PMCID: PMC3691310.
      Citations: 19     Fields:    Translation:AnimalsCells
    216. Sabry M, Halder SK, Allah AS, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational study. Int J Womens Health. 2013; 5:93-100. PMID: 23467803; PMCID: PMC3589082.
      Citations: 63     
    217. Gangula PR, Dong YL, Al-Hendy A, Richard-Davis G, Montgomery-Rice V, Haddad G, Millis R, Nicholas SB, Moseberry D. Protective cardiovascular and renal actions of vitamin D and estrogen. Front Biosci (Schol Ed). 2013 01 01; 5(1):134-48. PMID: 23277041; PMCID: PMC3673780.
      Citations: 8     Fields:    Translation:HumansAnimals
    218. Thota C, Farmer T, Garfield RE, Menon R, Al-Hendy A. Vitamin D elicits anti-inflammatory response, inhibits contractile-associated proteins, and modulates Toll-like receptors in human myometrial cells. Reprod Sci. 2013 Apr; 20(4):463-75. PMID: 23012315; PMCID: PMC3823395.
      Citations: 28     Fields:    Translation:HumansCells
    219. Peggs KJ, Nguyen H, Enayat D, Keller NR, Al-Hendy A, Raj SR. Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome. Int J Gynaecol Obstet. 2012 Sep; 118(3):242-6. PMID: 22721633; PMCID: PMC3413773.
      Citations: 14     Fields:    Translation:Humans
    220. Sabry M, Ait Allah AS, Roshdy E, Al-Hendy A. Laparoscopic management of a large torted ovarian cyst in an adolescent virgin: a case report. Int J Womens Health. 2012; 4:223-5. PMID: 22675267; PMCID: PMC3367404.
      Citations:    
    221. Halder SK, Sharan C, Al-Hendy A. 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod. 2012 Apr; 86(4):116. PMID: 22302692; PMCID: PMC3338660.
      Citations: 60     Fields:    Translation:Animals
    222. Vargis E, Brown N, Williams K, Al-Hendy A, Paria BC, Reese J, Mahadevan-Jansen A. Detecting biochemical changes in the rodent cervix during pregnancy using Raman spectroscopy. Ann Biomed Eng. 2012 Aug; 40(8):1814-24. PMID: 22411265; PMCID: PMC3739433.
      Citations: 12     Fields:    Translation:Animals
    223. Ghadami M, El-Demerdash E, Zhang D, Salama SA, Binhazim AA, Archibong AE, Chen X, Ballard BR, Sairam MR, Al-Hendy A. Bone marrow transplantation restores follicular maturation and steroid hormones production in a mouse model for primary ovarian failure. PLoS One. 2012; 7(3):e32462. PMID: 22412875; PMCID: PMC3296713.
      Citations: 21     Fields:    Translation:Animals
    224. Sabry M, Al-Hendy A. Medical treatment of uterine leiomyoma. Reprod Sci. 2012 Apr; 19(4):339-53. PMID: 22378865; PMCID: PMC3343067.
      Citations: 62     Fields:    Translation:Humans
    225. Sabry M, Al-Hendy A. Innovative oral treatments of uterine leiomyoma. Obstet Gynecol Int. 2012; 2012:943635. PMID: 22518167; PMCID: PMC3306913.
      Citations: 24     
    226. Nair S, Al-Hendy A, Tamboli RA, Marks-Shulman PA, Abumrad NN. Increased COMT expression in PCOS biology. Mol Cell Endocrinol. 2012 May 15; 355(1):188-9. PMID: 22342814.
      Citations:    Fields:    Translation:Humans
    227. Thota C, Menon R, Wentz MJ, Fortunato SJ, Bartlett J, Drobek CO, Nair S, Al-Hendy A. A single-nucleotide polymorphism in the fetal catechol-O-methyltransferase gene is associated with spontaneous preterm birth in African Americans. Reprod Sci. 2012 Feb; 19(2):135-42. PMID: 22158829; PMCID: PMC3343133.
      Citations: 5     Fields:    Translation:Humans
    228. Nair S, Al-Hendy A. Adipocytes enhance the proliferation of human leiomyoma cells via TNF-a proinflammatory cytokine. Reprod Sci. 2011 Dec; 18(12):1186-92. PMID: 22096007; PMCID: PMC3343097.
      Citations: 23     Fields:    Translation:HumansCells
    229. Hassan MH, Fouad H, Bahashwan S, Al-Hendy A. Towards non-surgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat model. Hum Reprod. 2011 Nov; 26(11):3008-18. PMID: 21896544; PMCID: PMC3196875.
      Citations: 7     Fields:    Translation:AnimalsCells
    230. Goodwin JS, Al-Hendy A, Halder SK. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011 Apr; 96(4):E754-62. PMID: 21289245; PMCID: PMC3070259.
      Citations: 74     Fields:    Translation:HumansCells
    231. Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril. 2011 Jan; 95(1):247-53. PMID: 20736132; PMCID: PMC2992588.
      Citations: 68     Fields:    Translation:HumansCells
    232. Ghadami M, El-Demerdash E, Salama SA, Binhazim AA, Archibong AE, Chen X, Ballard BR, Sairam MR, Al-Hendy A. Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(-/-) FORKO mice. Mol Hum Reprod. 2010 Apr; 16(4):241-50. PMID: 20086006; PMCID: PMC2834408.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    233. Zhang D, Al-Hendy M, Richard-Davis G, Montgomery-Rice V, Sharan C, Rajaratnam V, Khurana A, Al-Hendy A. Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice. Am J Obstet Gynecol. 2010 Mar; 202(3):289.e1-9. PMID: 20074693; PMCID: PMC2834812.
      Citations: 39     Fields:    Translation:AnimalsCells
    234. Zhang D, Al-Hendy M, Richard-Davis G, Montgomery-Rice V, Rajaratnam V, Al-Hendy A. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil Steril. 2010 Oct; 94(5):1887-93. PMID: 19819432; PMCID: PMC2891261.
      Citations: 35     Fields:    Translation:HumansAnimalsCells
    235. Harirah H, Thota C, Wentz MJ, Zaman W, Al-Hendy A. Elevated expression of catechol-O-methyltransferase is associated with labor and increased prostaglandin E(2) production by human fetal membranes. Am J Obstet Gynecol. 2009 Nov; 201(5):496.e1-7. PMID: 19664748; PMCID: PMC2784115.
      Citations: 4     Fields:    Translation:Humans
    236. Atta HM, Al-Hendy A, El-Rehany MA, Dewerchin M, Abdel Raheim SR, Abdel Ghany H, Fouad R. Adenovirus-mediated overexpression of human tissue plasminogen activator prevents peritoneal adhesion formation/reformation in rats. Surgery. 2009 Jul; 146(1):12-7. PMID: 19541005.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    237. Atta HM, Al-Hendy A, Salama SA, Shaker OG, Hammam OA. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation. Liver Int. 2009 Aug; 29(7):1022-30. PMID: 19515220.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    238. Hassan MH, Othman EE, Hornung D, Al-Hendy A. Gene therapy of benign gynecological diseases. Adv Drug Deliv Rev. 2009 Aug 10; 61(10):822-35. PMID: 19446586; PMCID: PMC4477532.
      Citations: 13     Fields:    Translation:HumansAnimals
    239. Hassan M, Zhang D, Salama S, Hamada F, Arafa H, Fouad H, Walker C, Al-Hendy A. Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model. Gynecol Obstet Invest. 2009; 68(1):19-32. PMID: 19325244; PMCID: PMC4677717.
      Citations: 13     Fields:    Translation:AnimalsCells
    240. Hassan MH, Salama SA, Zhang D, Arafa HM, Hamada FM, Fouad H, Walker CC, Al-Hendy A. Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model. Fertil Steril. 2010 Jan; 93(1):239-50. PMID: 19144333; PMCID: PMC2812608.
      Citations: 18     Fields:    Translation:AnimalsCells
    241. Salama SA, Kamel M, Awad M, Nasser AH, Al-Hendy A, Botting S, Arrastia C. Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase. Int J Cancer. 2008 Sep 15; 123(6):1246-54. PMID: 18566989.
      Citations: 17     Fields:    Translation:HumansCells
    242. Othman EE, Zhu ZB, Curiel DT, Khatoon N, Salem HT, Khalifa EA, Al-Hendy A. Toward gene therapy of endometriosis: transductional and transcriptional targeting of adenoviral vectors to endometriosis cells. Am J Obstet Gynecol. 2008 Aug; 199(2):117.e1-6. PMID: 18674655; PMCID: PMC4191855.
      Citations: 5     Fields:    Translation:HumansCells
    243. Heo MY, Salama SA, Khatoon N, Al-Hendy A, Au WW. Abrogation of estrogen receptor signaling augments cytotoxicity of anticancer drugs on CaSki cervical cancer cells. Anticancer Res. 2008 Jul-Aug; 28(4B):2181-7. PMID: 18751393; PMCID: PMC4477542.
      Citations: 3     Fields:    Translation:HumansCells
    244. Othman Eel-D, Hornung D, Al-Hendy A. Biomarkers of endometriosis. Expert Opin Med Diagn. 2008 Jul; 2(7):741-52. PMID: 23495814.
      Citations: 8     Fields:    
    245. Xu X, Othman Eel-D, Issaq HJ, Hornung D, Al-Hendy A, Veenstra TD. Multiplexed quantitation of endogenous estrogens and estrogen metabolites in human peritoneal fluid. Electrophoresis. 2008 Jun; 29(12):2706-13. PMID: 18512681; PMCID: PMC4297214.
      Citations: 4     Fields:    Translation:Humans
    246. Hassan MH, Eyzaguirre E, Arafa HM, Hamada FM, Salama SA, Al-Hendy A. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am J Obstet Gynecol. 2008 Aug; 199(2):156.e1-8. PMID: 18468574; PMCID: PMC4272582.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    247. Othman EE, Al-Hendy A. Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2008 Aug; 22(4):589-601. PMID: 18373954; PMCID: PMC4171730.
      Citations: 38     Fields:    Translation:Humans
    248. Azab SS, Salama SA, Hassan MH, Khalifa AE, El-Demerdash E, Fouad H, Al-Hendy A, Abdel-Naim AB. 2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft. Cancer Chemother Pharmacol. 2008 Oct; 62(5):893-902. PMID: 18253735.
      Citations: 3     Fields:    Translation:HumansAnimals
    249. Azab SS, Salama SA, Abdel-Naim AB, Khalifa AE, El-Demerdash E, Al-Hendy A. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells? Breast Cancer Res Treat. 2009 Jan; 113(1):9-19. PMID: 18228136.
      Citations: 7     Fields:    Translation:HumansCells
    250. Hassan MH, Khatoon N, Curiel DT, Hamada FM, Arafa HM, Al-Hendy A. Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells. Hum Reprod. 2008 Mar; 23(3):514-24. PMID: 18184643.
      Citations: 12     Fields:    Translation:HumansCells
    251. Zhang D, Fouad H, Zoma WD, Salama SA, Wentz MJ, Al-Hendy A. Expression of stem and germ cell markers within nonfollicle structures in adult mouse ovary. Reprod Sci. 2008 Feb; 15(2):139-46. PMID: 18089589.
      Citations: 16     Fields:    Translation:AnimalsCells
    252. Salih SM, Salama SA, Jamaluddin M, Fadl AA, Blok LJ, Burger CW, Nagamani M, Al-Hendy A. Progesterone-mediated regulation of catechol-O-methyl transferase expression in endometrial cancer cells. Reprod Sci. 2008 Feb; 15(2):210-20. PMID: 18089588.
      Citations: 4     Fields:    Translation:HumansCells
    253. Ghadami M, Salama SA, Khatoon N, Chilvers R, Nagamani M, Chedrese PJ, Al-Hendy A. Toward gene therapy of primary ovarian failure: adenovirus expressing human FSH receptor corrects the Finnish C566T mutation. Mol Hum Reprod. 2008 Jan; 14(1):9-15. PMID: 18084009.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    254. Wentz MJ, Shi SQ, Shi L, Salama SA, Harirah HM, Fouad H, Garfield RE, Al-Hendy A. Treatment with an inhibitor of catechol-O-methyltransferase activity reduces preterm birth and impedes cervical resistance to stretch in pregnant rats. Reproduction. 2007 Dec; 134(6):831-9. PMID: 18042640.
      Citations: 4     Fields:    Translation:Animals
    255. Hassan MH, Salama SA, Arafa HM, Hamada FM, Al-Hendy A. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression. J Clin Endocrinol Metab. 2007 Oct; 92(10):3949-57. PMID: 17635941.
      Citations: 17     Fields:    Translation:AnimalsCells
    256. Saed GM, Al-Hendy A, Salama SA, Diamond MP. Adenovirus-mediated expression of cyclooxygenase-2 antisense reverse abnormal genetic profile of human adhesion fibroblasts. Fertil Steril. 2008 May; 89(5 Suppl):1455-60. PMID: 17624339.
      Citations: 6     Fields:    Translation:HumansCells
    257. Salih SM, Jamaluddin M, Salama SA, Fadl AA, Nagamani M, Al-Hendy A. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome. Fertil Steril. 2008 May; 89(5 Suppl):1414-21. PMID: 17612537.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    258. Salama SA, Jamaluddin M, Kumar R, Hassan MH, Al-Hendy A. Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms. J Steroid Biochem Mol Biol. 2007 Nov-Dec; 107(3-5):253-61. PMID: 17689241; PMCID: PMC2254140.
      Citations: 7     Fields:    Translation:HumansCells
    259. Othman Eel-D, Hornung D, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008 Apr; 137(2):240-6. PMID: 17582674.
      Citations: 38     Fields:    Translation:Humans
    260. Salih S, Xu X, Veenstra TD, Duleba AJ, Fouad H, Nagamani M, Al-Hendy A. Lower levels of urinary 2-hydroxyestrogens in polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Aug; 92(8):3285-91. PMID: 17535988.
      Citations: 4     Fields:    Translation:Humans
    261. Salih SM, Salama SA, Fadl AA, Nagamani M, Al-Hendy A. Expression and cyclic variations of catechol-O-methyl transferase in human endometrial stroma. Fertil Steril. 2008 Sep; 90(3):789-97. PMID: 17418156; PMCID: PMC4477541.
      Citations: 6     Fields:    Translation:HumansCells
    262. Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, Hankins GD, Saade GR. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol. 2007 Apr; 196(4):396.e1-7; discussion 396.e7. PMID: 17403433.
      Citations: 87     Fields:    Translation:Animals
    263. Othman EE, Salama S, Ismail N, Al-Hendy A. Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells. Fertil Steril. 2007 Aug; 88(2):462-71. PMID: 17343855.
      Citations: 13     Fields:    Translation:HumansCells
    264. Au WW, Abdou-Salama S, Al-Hendy A, Sierra-Torres CH. Environmental risk factors for prevention and molecular intervention of cervical cancer. Int J Hyg Environ Health. 2007 Dec; 210(6):671-678. PMID: 17157560.
      Citations: 10     Fields:    Translation:Humans
    265. Wentz MJ, Jamaluddin M, Garfield RE, Al-Hendy A. Regulation of catechol-O-methyltransferase expression in human myometrial cells. Obstet Gynecol. 2006 Dec; 108(6):1439-47. PMID: 17138778; PMCID: PMC4221853.
      Citations: 3     Fields:    Translation:HumansCells
    266. Au WW, Abdou-Salama S, Al-Hendy A. Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene. Gynecol Oncol. 2007 Feb; 104(2):276-80. PMID: 17137618; PMCID: PMC1831876.
      Citations: 10     Fields:    Translation:HumansCells
    267. Salama SA, Nasr AB, Dubey RK, Al-Hendy A. Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids. J Soc Gynecol Investig. 2006 Dec; 13(8):542-50. PMID: 17088081.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    268. Salama SA, Kamel M, Christman G, Wang HQ, Fouad HM, Al-Hendy A. Gene therapy of uterine leiomyoma: adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir treatment inhibits growth of human and rat leiomyoma cells in vitro and in a nude mouse model. Gynecol Obstet Invest. 2007; 63(2):61-70. PMID: 16954695.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    269. Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril. 2006 Sep; 86(3):686-93. PMID: 16860797.
      Citations: 42     Fields:    Translation:Humans
    270. Salama SA, Ho SL, Wang HQ, Tenhunen J, Tilgmann C, Al-Hendy A. Hormonal regulation of catechol-O-methyl transferase activity in women with uterine leiomyomas. Fertil Steril. 2006 Jul; 86(1):259-62. PMID: 16730007.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    271. Al-Hendy A, Salama S. Gene therapy and uterine leiomyoma: a review. Hum Reprod Update. 2006 Jul-Aug; 12(4):385-400. PMID: 16603566.
      Citations: 27     Fields:    Translation:HumansAnimals
    272. Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006 Feb; 13(2):136-44. PMID: 16443508.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    273. Al-Hendy A, Lee EJ, Wang HQ, Copland JA. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol. 2004 Nov; 191(5):1621-31. PMID: 15547533.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    274. Young SL, Al-Hendy A, Copland JA. Potential nonhormonal therapeutics for medical treatment of leiomyomas. Semin Reprod Med. 2004 May; 22(2):121-30. PMID: 15164307.
      Citations: 3     Fields:    Translation:Humans
    275. Al-Hendy A, Moshynska O, Saxena A, Feyles V. Association between mutations of the follicle-stimulating-hormone receptor and repeated twinning. Lancet. 2000 Sep 09; 356(9233):914. PMID: 11036902.
      Citations: 4     Fields:    Translation:Humans
    276. Al-Hendy A, Magliocco AM, Al-Tweigeri T, Braileanu G, Crellin N, Li H, Strong T, Curiel D, Chedrese PJ. Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model. Am J Obstet Gynecol. 2000 Mar; 182(3):553-9. PMID: 10739507.
      Citations: 9     Fields:    Translation:AnimalsCells
    277. Al-Hendy A. Enriching research culture in residency. Am J Obstet Gynecol. 1999 Nov; 181(5 Pt 1):1271. PMID: 10561660.
      Citations:    Fields:    Translation:Humans
    278. Al-Hendy A, Auersperg N. Applying the herpes simplex virus thymidine kinase/ganciclovir approach to ovarian cancer: an effective in vitro drug-sensitization system. Gynecol Obstet Invest. 1997; 43(4):268-75. PMID: 9194627.
      Citations: 9     Fields:    Translation:HumansCells
    279. Hortelano G, Al-Hendy A, Ofosu FA, Chang PL. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood. 1996 Jun 15; 87(12):5095-103. PMID: 8652822.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    280. Al-Hendy A, Hortelano G, Tannenbaum GS, Chang PL. Growth retardation--an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. Hum Gene Ther. 1996 Jan; 7(1):61-70. PMID: 8825869.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    281. Skurnik M, Venho R, Toivanen P, al-Hendy A. A novel locus of Yersinia enterocolitica serotype O:3 involved in lipopolysaccharide outer core biosynthesis. Mol Microbiol. 1995 Aug; 17(3):575-94. PMID: 8559076.
      Citations: 34     Fields:    Translation:Cells
    282. al-Hendy A, Hortelano G, Tannenbaum GS, Chang PL. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts--an alternate approach to somatic gene therapy. Hum Gene Ther. 1995 Feb; 6(2):165-75. PMID: 7734517.
      Citations: 3     Fields:    Translation:AnimalsCells
    283. Zhang L, al-Hendy A, Toivanen P, Skurnik M. Genetic organization and sequence of the rfb gene cluster of Yersinia enterocolitica serotype O:3: similarities to the dTDP-L-rhamnose biosynthesis pathway of Salmonella and to the bacterial polysaccharide transport systems. Mol Microbiol. 1993 Jul; 9(2):309-21. PMID: 7692217.
      Citations: 36     Fields:    Translation:Cells
    284. al-Hendy A, Toivanen P, Skurnik M. Lipopolysaccharide O side chain of Yersinia enterocolitica O:3 is an essential virulence factor in an orally infected murine model. Infect Immun. 1992 Mar; 60(3):870-5. PMID: 1311707; PMCID: PMC257567.
      Citations: 30     Fields:    Translation:AnimalsCells
    285. al-Hendy A, Toivanen P, Skurnik M. Expression cloning of Yersinia enterocolitica O:3 rfb gene cluster in Escherichia coli K12. Microb Pathog. 1991 Jan; 10(1):47-59. PMID: 1857198.
      Citations: 24     Fields:    Translation:Cells
    286. al-Hendy A, Toivanen P, Skurnik M. Molecular cloning of Yersinia enterocolitica O:3 rfb region: evidence that temperature regulates the rfb region at the transcriptional level. Contrib Microbiol Immunol. 1991; 12:203-9. PMID: 1935091.
      Citations:    Fields:    Translation:Cells
    287. al-Hendy A, Toivanen P, Skurnik M. Rapid method for isolation and staining of bacterial lipopolysaccharide. Microbiol Immunol. 1991; 35(4):331-3. PMID: 1719357.
      Citations: 12     Fields:    Translation:Cells
    288. al-Hendy A, Toivanen P, Skurnik M. The effect of growth temperature on the biosynthesis of Yersinia enterocolitica O:3 lipopolysaccharide: temperature regulates the transcription of the rfb but not of the rfa region. Microb Pathog. 1991 Jan; 10(1):81-6. PMID: 1857201.
      Citations: 17     Fields:    Translation:Cells
    Al-Hendy's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (790)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _